1365-2710/asset/olbannerleft.jpg?v=1&s=aa84a968ef3e4c88817d0563e21aefa7efa42137)
1365-2710/asset/olbannerright.jpg?v=1&s=a095a2371a8570a4bffe4e80a3cfc0890f8e5615)
Case Report
You have free access to this content
Cannabis derivatives therapy for a seronegative stiff-person syndrome: a case report
Article first published online: 21 JUN 2012
DOI: 10.1111/j.1365-2710.2012.01365.x
© 2012 Blackwell Publishing Ltd
Additional Information
How to Cite
Vicente-Valor, M. I., Garcia-Llopis, P., Mejia Andujar, L., Antonino de la Camara, G., García del Busto, N., Lopez Tinoco, M. J., Quintana Vergara, B., Peiro Vilaplana, C., Dominguez Moran, J. A. and Sánchez Alcaraz, A. (2013), Cannabis derivatives therapy for a seronegative stiff-person syndrome: a case report. Journal of Clinical Pharmacy and Therapeutics, 38: 71–73. doi: 10.1111/j.1365-2710.2012.01365.x
Publication History
- Issue published online: 2 JAN 2013
- Article first published online: 21 JUN 2012
- Received 7 December 2011, Accepted 15 May 2012
References
- 1, . Progressive fluctuating muscular rigidity and spasm (“stiff-man” syndrome); report of a case and some observations in 13 other cases. Proc Staff Meet Mayo Clin1956;31:421–427.
- 2, , et al. Review of 23 patients affected by the stiff man syndrome: clinical subdivision into stiff trunk (man) syndrome, stiff limb syndrome, and progressive encephalomyelitis with rigidity. J Neurol Neurosurg Psychiatry1998;65:633–640.
- 3, . Stiff man syndrome and related conditions. Mov Disord2002;17:853–866.
- 4, , et al. Autoantibodies to GABAergic neurons and pancreatic beta cells in stiff-man syndrome. N Engl J Med1990;322:1555–1560.
- 5Sativex: European public assessment report. London: Medicines and Healthcare products Regulatory Agency, 2010. Available at: http://www.mhra.gov.uk/home/groups/par/documents/websiteresources/con084961.pdf (accessed 14 August 2011).
- 6, , . The Spanish version of the SF-36 Health Survey (the SF-36 health questionnaire): an instrument for measuring clinical results. Med Clin Barc1995;104:771–776.
- 7, , , . SF-36 health survey. Manual and interpretation guide. Boston, MA: The Health Institute, New England Medical Center, 1993.
- 8, . Rigidity and spasms from autoimmune encephalomyelopathies: stiff-person syndrome. Muscle Nerve2006;34:677–690.
- 9. Expert Abuse potential and psychoactive effects of delta-9-tetrahydrocannabinol and cannabidiol oromucosal spray (Sativex), a new cannabinoid medicine. Opin Drug Saf2011;10:675–685.
- 10, , , . THC and CBD oromucosal spray (Sativex®) in the management of spasticity associated with multiple sclerosis. Expert Rev Neurother2011;11:627–637.